Inactive Instrument

QUANTA

Equities

QNTA

US74766N1081

Quanta, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019

August 19, 2019 at 06:07 am

Quanta, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced total revenue was USD 317,477 compared to USD 24,666 a year ago. Operating loss was USD 1.890 million compared to USD 352,229 a year ago. Net loss was USD 1.906 million compared to USD 290,215 a year ago. Basic loss per share was USD 0.05 compared to USD 0.01 a year ago. For the half year, total revenue was USD 547,856 compared to USD 24,930 a year ago. Operating loss was USD 2.069 million compared to USD 607,320 a year ago. Net loss was USD 2.089 million compared to USD 545,306 a year ago. Basic loss per share was USD 0.05 compared to USD 0.02 a year ago.

Latest news about QUANTA

Quanta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
Quanta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-15	CI
Quanta, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-22	CI
Quanta, Inc. announced that it has received $0.075 million in funding from Trillium Partners LP	21-11-11	CI
Quanta, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-23	CI
Quanta, Inc. Appoints Grant Mikaelian and Pauline Ranjbar to the Board of Directors	21-07-02	CI
Quanta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-25	CI
Quanta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-15	CI
Quanta, Inc. Auditor Raises 'Going Concern' Doubt	21-04-14	CI
Quanta, Inc. completed the acquisition of 51% stake in Medolife International, Inc.	21-01-13	CI
Quanta, Inc. Announces Appointment of Arthur G. Mikaelian as Chief Executive Officer	20-12-22	CI
Quanta, Inc. Announces Appointment of Arthur G. Mikaelian as Member of the Board of Directors	20-12-22	CI
Quanta, Inc. entered into a Securities Exchange Agreement to acquire 51% stake in Medolife International, Inc.	20-12-21	CI
Quanta, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-12-18	CI
Quanta, Inc. Announces Change of CEO	20-11-18	CI
Quanta, Inc. Appoints Phil Sands as Member of the Board of Directors	20-11-13	CI
Quanta, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-19	CI
Quanta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-06-19	CI
Quanta, Inc. Begins to Ship its Quanta Branded Hand Sanitizer its Distribution Partners	20-05-29	CI
Quanta, Inc. Names Francisco Ortiz as Head of Sales	20-05-15	CI
Quanta, Inc. Announces Significant Advancements in ATP Production with Polarization Technology Platform	20-05-13	CI
Quanta, Inc. announced that it has received $0.341 million in funding	20-04-26	CI
Quanta, Inc. Announces the Addition of Eddy Pham to Advisory Board	20-04-16	CI
Quanta Announces Distribution Agreement with Hanson Faso Sales & Marketing	20-04-09	CI
Quanta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-03	CI

Chart QUANTA

Duration

Period

More charts

Company Profile

Quanta, Inc. is an applied science company focused on increasing energy levels in plant matter to increase performance within the human body. The Company is also specialized in potentiating rare naturally occurring elements to create and sustainable solutions. The Company's technology uses quantum mechanics to increase bioactivity of targeted molecules to enhance the desired effects. The Company supports product formulations in pain management, anti-inflammation, skincare, agriculture, nutritional supplements, and plant-based consumables.

Sector

More about the company